Martin Godbout

Founder at

BioContact (Québec), Inc.

Health Technology

Commercial Services

Finance

Profile

Martin Godbout is the founder of BioContact (Québec), Inc. (founded in 1994) and Genome Canada (founded in 2000).
He is currently a Director at Angiochem, Inc., Fonds Recherche sur Nature et les Technologies, Ataxia of Charlevoix-Saguenay Foundation, Montreal Invivo Organization, Fondation Sur Les Leucodystrophies, and Corporation Inno-centre du Québec.
He is also the President of Hodran Consultants, Inc. (since 2009).
Dr. Godbout has held former positions as Chairman of BioQuebec, Génome Québec, Inc., and Insitut de Recherche en Immunologie et en Cancérologie.
He was also a Director at Acasti Pharma, Inc. (2011), BioCapital Investment Advisors, Inc. (2003-2005), Mirati Therapeutics, Inc. (2002-2014), Asmacure Ltée, Conseil de la Science et de la Technologie du Québec (1996-2004), AmorChem Financial, Inc., and Senior Vice President at BioCapital Investment Advisors, Inc. He served as President & General Manager of Société Innovatech du Grand Montréal and holds the title of Principal at Order of Canada.
Dr. Godbout received his undergraduate degree from Université Laval in 1979 and holds a doctorate from the same institution.

Martin Godbout active positions

Companies	Position	Start
Angiochem, Inc. Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases	Director/Board Member	-
BioContact (Québec), Inc. BioContact (Québec), Inc. Medical/Nursing ServicesHealth Services Operates as a pharmaceutical partnership symposium which specializes in medicinal chemistry and the custom synthesis of small molecules and peptides	Founder	2010-01-04
Ataxia of Charlevoix-Saguenay Foundation	Director/Board Member	-
Hodran Consultants, Inc.	President	2009-09-30
Montreal Invivo Organization Montreal Invivo Organization Montreal Invivo Organization is a non-profit company based in Montréal, Canada.	Director/Board Member	-
Fonds Recherche sur Nature et les Technologies	Director/Board Member	-
Fondation Sur Les Leucodystrophies Fondation Sur Les Leucodystrophies Miscellaneous Commercial ServicesCommercial Services Offers leukodystrophy treatment services for children	Director/Board Member	-
Corporation Inno-centre du Québec Corporation Inno-centre du Québec Investment ManagersFinance Provides financial consulting and marketing services	Director/Board Member	2015-06-10

All active positions of Martin Godbout

Former positions of Martin Godbout

Companies	Position	End
MIRATI THERAPEUTICS	Chairman	2013-07-22
░░░░░░ ░░░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░ ░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░ ░░ ░░░░░░░ ░░ ░░ ░░ ░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░ ░░ ░░░░░░░░░░░░░	░░░░░░░░	-

See the detail of Martin Godbout's experience

Training of Martin Godbout

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Godbout's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	21
Grace Therapeutics, Inc. Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases	Health Technology
BioCapital Investment Advisors, Inc. BioCapital Investment Advisors, Inc. Investment ManagersFinance The fundamental investment objective of BioCapital is to provide investors superior capital appreciation by investing in equity securities of public companies with high growth potential in biotechnology industries. They seek to achieve this fundamental objective by investing in a diversified portfolio of public companies primarily in the following sectors of the biotechnology industry: therapeutics in the fields of cancer, cardiology, infectious diseases, immune system and central nervous system. The firm also invests in companies developing platform technologies in the fields on genomics and proteomics, drug delivery, theranostics, nanotechnology and monoclonal antibody.	Finance
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies	Health Technology
Angiochem, Inc. Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases	Health Technology
Société Innovatech du Grand Montréal
Université Laval Université Laval Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Asmacure Ltée Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases	Health Technology
BioQuebec BioQuebec BiotechnologyHealth Technology Manufactures biotech products	Health Technology
Order of Canada Order of Canada Miscellaneous Commercial ServicesCommercial Services Honorary society	Commercial Services
Genome Canada Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services	Commercial Services
BioContact (Québec), Inc. BioContact (Québec), Inc. Medical/Nursing ServicesHealth Services Operates as a pharmaceutical partnership symposium which specializes in medicinal chemistry and the custom synthesis of small molecules and peptides	Health Services
Génome Québec, Inc. Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomics and DNA in Quebec	Commercial Services
Conseil de la Science et de la Technologie du Québec Conseil de la Science et de la Technologie du Québec General GovernmentGovernment Advisory commission on science and technology	Government
Fonds Recherche sur Nature et les Technologies
Ataxia of Charlevoix-Saguenay Foundation
Montreal Invivo Organization Montreal Invivo Organization Montreal Invivo Organization is a non-profit company based in Montréal, Canada.
Hodran Consultants, Inc.
Fondation Sur Les Leucodystrophies Fondation Sur Les Leucodystrophies Miscellaneous Commercial ServicesCommercial Services Offers leukodystrophy treatment services for children	Commercial Services
AmorChem Financial, Inc. AmorChem Financial, Inc. Financial ConglomeratesFinance Provides financial investment services	Finance
Insitut de Recherche en Immunologie et en Cancérologie Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Engages in research and development in immunology and cancer	Commercial Services
Corporation Inno-centre du Québec Corporation Inno-centre du Québec Investment ManagersFinance Provides financial consulting and marketing services	Finance